Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2021
New Titles 2020
Price and Ordering Information
Subscription Rates 2021
Subscription Rates 2020
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Marketing Opportunities
Institutional Membership
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2020
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Media Partners
Partnering Events
Promotional Services
For Authors, Editors & Librarians
Author Benefits
Author's Benefits Guide
Author Reprints
Authorship
Copyediting Services
Editorial Policies
FAQs for e-prints/reprints
Increase Visibility of your Article
General FAQs
Guidelines for Guest Editors
Journal Catalog 2020
Journal Catalog 2021
Kudos
Library Recommendations
Manuscript Transfer Facility
Online Manuscript Submission
Order Bulk ePrints
Order Bulk Reprints
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Self-Archiving Policies
Table of Contents Alert
Trial Requests
Webinars
Contact Us
Track Your Manuscript:
Enter Correct Manuscript Reference Number:
Submit Reference Number
Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Impact Factor:
2.912
5 Year Impact Factor:
2.947
Subscribe to this Journal
Call for Editors
Book Proposal
Join Editorial Board
New Journal Proposal
Become a Reviewer
Become an Executive Guest Editor
Thematic Issue Proposal
Submit Abstract Online
Contents
Current Cancer Drug Targets
,
Volume 16
- Number 8
Editorial
Open Access
Editorial (Thematic Issue: Pathogenetic Mechanisms of CLL - A Target in Therapy)
,
16
(
8
):
651
Maria Bozko, Monika Podhorecka, Arkadiusz Macheta, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko
DOI:
10.2174/156800961608160902101746
View Editorial
Permissions
Download Free
Review Article
Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?
,
16
(
8
):
652
- 658
Monika Podhorecka, Arkadiusz Macheta, Maria Bozko, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko
DOI:
10.2174/1568009616666160427103930
×
Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia
,
16
(
8
):
659
- 668
Michele Dal Bo, Erika Tissino, Dania Benedetti, Chiara Caldana, Riccardo Bomben, Giovanni Del Poeta, Gianluca Gaidano, Francesca Maria Rossi, Pietro Bulian, Antonella Zucchetto and Valter Gattei
DOI:
10.2174/1568009616666160809102219
×
Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
Targeting Signaling Pathways in Chronic Lymphocytic Leukemia
,
16
(
8
):
669
- 688
Alice F. Muggen, Simar P. Singh, Rudi W. Hendriks and Anton W. Langerak
DOI:
10.2174/1568009616666160408145623
×
Targeting Signaling Pathways in Chronic Lymphocytic Leukemia
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia
,
16
(
8
):
689
- 700
John C. Riches and John G. Gribben
DOI:
10.2174/1568009616666160408145741
×
Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
,
16
(
8
):
701
- 709
Lukas Smolej
DOI:
10.2174/1568009616666160408150032
×
Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
,
16
(
8
):
710
- 720
Lukas Smolej
DOI:
10.2174/1568009616666160408145850
×
Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Research Article
Proteomic and Metabolic Signatures of Esophageal Squamous Cell Carcinoma
,
16
(
8
):
721
- 736
Kubra Karagoz, Heather L. Lehman, Douglas B. Stairs, Raghu Sinha and Kazim Y. Arga
DOI:
10.2174/1568009616666160203113721
×
Proteomic and Metabolic Signatures of Esophageal Squamous Cell Carcinoma
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board
COPE Compliant
About the Journal
⇨ Journal Home
⇨ Editorial Policies
⇨ Editorial Board
⇨ Meet the Executive Guest Editor(s)
⇨ Board Recruitment Workflow
⇨ Join Editorial Board
⇨ Indexing Information
⇨ Announcements
⇨ Endorsements
⇨ Authors' Comments
For Authors
⇨ Author Guidelines
⇨ Animated Abstracts
⇨ Increase Visibility of your Article
⇨ Submit Abstracts Online
⇨ Submit Manuscripts Online
⇨ Open Access Funding
⇨ Publishing Ethics and Rectitude
⇨ Archiving Policies
⇨ Manuscript Transfer Facility
For Guest Editors
⇨ Thematic Issue Proposal
⇨ Forthcoming Thematic Issues
⇨ Guest Editor Guidelines
For Reviewers
⇨ Reviewer Guidelines
⇨ Peer Review Workflow
⇨ Become a Reviewer
For Librarians & Readers
⇨ Contents & Abstracts
⇨ Open Access Articles
⇨ Editor's Choice
⇨ Free Copies Online
⇨ Thematic Issues
⇨ Journal Catalog 2020
⇨ Journal Catalog 2021
⇨ Most Accessed Articles
⇨ Most Cited Articles
⇨ PURCHASE ARTICLES
⇨ Order Reprints
⇨ Subscribe
⇨ Trial Requests
⇨ Library Recommendation
Quick Links
⇨ Journal's New Website
⇨ Advertise with Us
⇨ Brand Ambassadors
⇨ Newsletter
⇨ Download PDF Flyer
⇨ Table of Contents Alert
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Advertisement
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2021 Bentham Science
|
Privacy Policy